Darb-ESA 25 Injection
Marketer
Septalyst Lifesciences Pvt.Ltd.
Salt Composition
Darbepoetin alfa (25mcg)
Overview Darb-ESA 25 Injection
Erythropoiesis-stimulating agent Darb-ESA 25 Injection treats anemia stemming from chronic kidney disease or chemotherapy. Its mechanism involves boosting red blood cell production in the bone marrow. Administered under medical supervision, Darb-ESA 25 requires cautious use due to potential serious adverse reactions. Treatment should be managed by a specialist, with diligent adherence to their instructions. Common side effects encompass abdominal discomfort, hypertension, skin eruptions, injection site soreness, dyspnea, cough, and peripheral swelling. Report symptoms of severe hypertension, including intense headache, visual disturbances, nausea, vomiting, or convulsions, immediately. Regular blood tests will monitor electrolyte levels (potassium), hemoglobin, and blood cell counts. Discontinue use and seek medical advice for sudden shortness of breath or skin rashes. Prior to commencing treatment, disclose any history of heart disease, hypertension, seizures, or stroke. Pregnant, breastfeeding, or intending to conceive or breastfeed individuals should consult their physician regarding safety.
Primary Ingredients of Darb-ESA 25 Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Darb-ESA 25 Injection
Managing Anemia in Chronic Kidney Disease and Cancer Chemotherapy
Major Benefits of Darb-ESA 25 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Darb-ESA 25 Injection:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Darb-ESA 25 Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
How Darb-ESA 25 Injection works:
Darb-ESA 25 Injection is an erythropoietin-based medication that boosts red blood cell production. This is achieved by stimulating the bone marrow's activity, thereby increasing the generation of red blood cells within this crucial blood-forming tissue.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Darb-ESA 25 Injection may pose unknown risks. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
The use of Darb-ESA 25 Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
Administration of Darb-ESA 25 Injection while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer to breast milk, posing a risk of infant harm.
DrivingSAFE
Driving ability is typically unaffected by Darb-ESA 25 Injection.
KidneySAFE IF PRESCRIBED
Darbepoetin alfa 25 mcg injection poses no safety concerns for patients with renal impairment. No dosage modification is advised for this medication.
LiverCAUTION
Patients with hepatic impairment should use Darb-ESA 25 Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Darb-ESA 25 Injection :
Should you forget a Darb-ESA 25 Injection, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Darb-ESA 25 Injection
| Label | Value |
|---|---|
| Chemical Type | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | Erythropoietin-stimulating drug |
3,018 People bought this recently